In conclusion, IL-18BP deficiency in mice alters AMPs production and leads to gut dysbiosis that shares similarities with gut microbiota signature of MASLD/MASH patients. The gene discussed is IL18BP; the disease is metabolic dysfunction-associated steatotic liver disease.